drugset / Trial / NCT04687514
Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
Phase 2
Completed
26 enrolled
University Hospital, Basel, Switzerland
Goldschmidt-Jacobson Foundation · collabSwiss National Science Foundation · collab
RandomizedCrossoverTriple-blindBasic science
Summary
This placebo-controlled, double-blind crossover study is to evaluate the GLP-1 analogue dulaglutide regarding changes in sexuality, the mood and the reproductive axis in healthy men.
Timeline
- Start
- 2021-05-05
- Primary completion
- 2022-09-05
- Completion
- 2022-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dulaglutide | Peptide | 3 mg | Subcutaneous |